相关实验视频
Updated: Feb 13, 2026

09:12
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
10.1K
心脏移植Treg疗法的临床前和临床发展:批判性评估和翻译挑战
Konstantinos Mengrelis1, Laurenz Wolner2, Rayna Lellis Lakatos3
1Medical University of Vienna, Department of Cardiac and Thoracic Aortic Surgery, Vienna, Austria.
Human immunology
|February 11, 2026
概括
调节性T细胞 (Tregs) 在心脏移植耐受性方面表现有前途,减少免疫抑制. 在临床转化方面仍然存在挑战,但工程Tregs和甲状腺衍生Tregs提供了未来的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 移植科学 移植科学
- 细胞疗法细胞疗法
背景情况:
- 调节性T细胞 (Tregs) 对免疫耐受性至关重要.
- 在器官移植中,Tregs提供了一种减少免疫抑制的潜在策略.
- 心脏移植面临着慢性排斥和免疫抑制的挑战.
研究的目的:
- 审查Treg治疗在心脏移植中的临床前和临床证据.
- 确定Treg翻译在心脏全移植受体中的障碍物和新兴策略.
- 概述在临床实践中推进Treg治疗的研究重点.
主要方法:
- 在小鼠模型中进行的临床前研究的批判性评估.
- 对和肝移植的I/II期临床试验的分析.
- 评估新兴的Treg工程和电池源.
主要成果:
- 临床前Tregs延长了异种移植的存活时间,并预防了血管病变.
- 临床试验表明Treg疗法是安全的和可行的,减少免疫抑制.
- 通过CAR工程的Tregs和来自胸腺的Tregs显示出有希望的临床前和早期临床结果.
结论:
- 特雷格疗法对心脏移植有很大的潜力,但面临着翻译障碍.
- 克服Treg持久性,稳定性和制造方面的障碍至关重要.
- 需要进一步的研究和临床试验,以确定Treg治疗心脏异位移植.
相关概念视频
Preclinical Development: Overview
6.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.0K
Development of the Heart
2.7K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.7K
Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Heart Failure III: Clinical Manifestations
637
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
637
Translation
157.3K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.3K

